1. Involvement of indoleamine 2,3-dioxygenase in impairing tumor-infiltrating CD8 T-cell functions in esophageal squamous cell carcinoma.
- Author
-
Zhang G, Liu WL, Zhang L, Wang JY, Kuang MH, Liu P, Lin YH, Dai SQ, and Du J
- Subjects
- CD8-Positive T-Lymphocytes drug effects, CD8-Positive T-Lymphocytes immunology, CD8-Positive T-Lymphocytes pathology, Carcinoma, Squamous Cell pathology, Carcinoma, Squamous Cell physiopathology, Cell Line, Tumor, Cell Proliferation drug effects, Culture Media, Conditioned pharmacology, Cytotoxicity, Immunologic drug effects, Disease Progression, Esophageal Neoplasms pathology, Esophageal Neoplasms physiopathology, Female, Gene Expression Regulation, Neoplastic, Humans, Indoleamine-Pyrrole 2,3,-Dioxygenase genetics, Indoleamine-Pyrrole 2,3,-Dioxygenase immunology, Interferon-gamma metabolism, Lymphocytes, Tumor-Infiltrating drug effects, Lymphocytes, Tumor-Infiltrating immunology, Lymphocytes, Tumor-Infiltrating pathology, Male, Neoplasm Staging, Tumor Escape, Tumor Microenvironment immunology, CD8-Positive T-Lymphocytes metabolism, Carcinoma, Squamous Cell enzymology, Carcinoma, Squamous Cell immunology, Esophageal Neoplasms enzymology, Esophageal Neoplasms immunology, Indoleamine-Pyrrole 2,3,-Dioxygenase metabolism, Lymphocytes, Tumor-Infiltrating metabolism
- Abstract
The indoleamine 2,3-dioxygenase-(IDO-) mediated microenvironment plays an important role in tumor immune escape. However, the inhibitory effects of IDO on the CD8(+) tumour-infiltrating lymphocytes (CD8(+) TILs) in esophageal squamous cell carcinoma (ESCC) have not been clarified yet. Here, we found that the level of IDO expression in ESCC tumor specimens correlated with a reduction in the number of CD8(+) TILs. Patients with high IDO expression and a low number of CD8(+) TILs had significantly impaired overall survival time. IDO expression and functional enzyme activity in ESCC cell lines could be induced by IFNγ. When exposed to the milieu generated by IDO-expressing Eca109 cells, the CD8(+) TILs were suppressed in proliferation, and their cytolytic functions against target tumor cells were lost. These results suggested that impairing CD8(+) TIL functions by IDO expressed in ESCC possibly contributed to the finding that patients with higher IDO expression have more aggressive disease progression and shorter overall survival time.
- Published
- 2011
- Full Text
- View/download PDF